Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Equity Ratio (2020 - 2025)

RxSight (RXST) has disclosed Equity Ratio for 6 consecutive years, with 0.88 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio changed 0.15% year-over-year to 0.88, compared with a TTM value of 0.88 through Dec 2025, changed 0.15%, and an annual FY2025 reading of 0.88, changed 0.15% over the prior year.
  • Equity Ratio was 0.88 for Q4 2025 at RxSight, down from 0.89 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.9 in Q2 2024 and bottomed at 3.3 in Q2 2021.
  • Average Equity Ratio over 5 years is 0.59, with a median of 0.88 recorded in 2023.
  • Peak annual rise in Equity Ratio hit 119.97% in 2022, while the deepest fall reached 16.79% in 2022.
  • Year by year, Equity Ratio stood at 0.72 in 2021, then dropped by 16.54% to 0.6 in 2022, then surged by 46.73% to 0.88 in 2023, then rose by 0.5% to 0.88 in 2024, then increased by 0.15% to 0.88 in 2025.
  • Business Quant data shows Equity Ratio for RXST at 0.88 in Q4 2025, 0.89 in Q3 2025, and 0.9 in Q2 2025.